News-Medical.Net on MSN1d
Improving sepsis risk assessment using a two-stage transformer modelSepsis, a life-threatening condition caused by the body's dysregulated response to infection, remains a leading cause of ...
A groundbreaking study introduces a novel Transformer-based time-series framework designed to predict daily risk alerts for ...
Q4 2024 Earnings Call Transcript March 13, 2025 Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed ...
Health eCareers on MSN4d
Mastering New Technology in HealthcareRemarkable technological advancements have shaped the history of medicine for over 150 years. Historical breakthroughs have ...
Prognostic algorithms based on deep learning have shown promise in detecting the onset of sepsis hours before the actual event but use a large number of biomarkers, including vital signs and ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed primary efficacy endpoint of reduction in bloodstream inf ...
Recent studies have identified microRNAs (miRNAs), a class of small RNA molecules, as potential biomarkers for diagnosing and predicting outcomes in sepsis patients. However, the results of these ...
News-Medical.Net on MSN6d
New approach shows promise for uncovering potential sepsis treatmentsThe immune system typically can ramp up the body's defenses to clear out an invading threat without issue. Glitches can ...
Similar biosensors have been developed for the monitoring of electrolytes in sweat, biomarkers in interstitial fluid near the skin surface, and to report on the function of internal tissues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback